Diaphragm ultrasonography as a monitor in assessing antagonistic effect of sugammadex on rocuronium in patients with Child-Pugh grades A and B

Diaphragm ultrasonography as a monitor in assessing antagonistic effect of sugammadex on rocuronium in patients with Child-Pugh grades A and B

BackgroundAlthough diaphragm ultrasound can be used for detecting residual neuromuscular blockade post-surgery, there exists notable dearth in contemporary research exploring the correlation between preoperative Child-Pugh classification and the effectiveness of sugammadex in reversing rocuronium-in...

Full description

Bibliographic Details
Main Authors:	Yan Sun, Shujun Sun, Rui Chen, Jiwei Shen, Xiangdong Chen, Yun Lin, Shanglong Yao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Medicine
Subjects:	Child-Pugh grades diaphragm ultrasonography neuromuscular monitoring postoperative residual curarization rocuronium sugammadex
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1370021/full

Similar Items

Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
by: Ismar Lima Cavalcanti, et al.
Published: (2021-01-01)

Retrospective Study of the Restoration of Neuromuscular Blockage with Sugammadex in Newborns Who Used Rocuronium
by: Hacer Şebnem Türk, et al.
Published: (2019-07-01)

Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
by: Abdulhamid Alsaeed, et al.
Published: (2017-01-01)

Treatment of rocuronium-induced anaphylaxis using sugammadex - A case report -
by: Sun-Min Kim, et al.
Published: (2021-01-01)

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study
by: Ákos I. Fábián, et al.
Published: (2019-05-01)

Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial
by: Iacopo Cappellini, et al.
Published: (2018-02-01)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01)

Anaphylactic shock after sugammadex administration, induced by formation of a sugammadex-rocuronium complex -a case report-
by: Gunn Hee Kim, et al.
Published: (2019-10-01)

Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report
by: Shigeaki Kurita, et al.
Published: (2016-10-01)

Effects of hyperthermia on the effective concentration of rocuronium and sugammadex-mediated reversal in isolated phrenic nerve hemidiaphragm preparations of rats
by: Jin Sun Kim, et al.
Published: (2020-08-01)

Comparison of emergence agitation between succinylcholine and rocuronium-sugammadex in adults following closed reduction of a nasal bone fracture: a prospective randomized controlled trial
by: Seok-Jin Lee, et al.
Published: (2019-12-01)

The effect of rocuronium and sugammadex on progesterone levels in pregnant rabbits under general anesthesia
by: Rukiye TÜRK, et al.
Published: (2018-12-01)

Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
by: Shu Chung Choi, et al.
Published: (2020-08-01)

Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
by: Woon Seok Kang, et al.
Published: (2017-04-01)

The effect of magnesium sulfate concentration on the effective concentration of rocuronium, and sugammadex-mediated reversal, in isolated left phrenic nerve hemi-diaphragm preparations from the rat
by: Choon-kyu Cho, et al.
Published: (2018-10-01)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
by: Sang-Hwan Ji, et al.
Published: (2023-04-01)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
by: Tiffany Woo, et al.
Published: (2013-12-01)

Life-threatening rocuronium-induced anaphylactic shock without cutaneous manifestations successfully reversed with sugammadex: a case report
by: Yoshiaki Takise, et al.
Published: (2020-12-01)

Intérêt de l'algorithme rocuronium - sugammadex dans la laryngoscopie directe en suspension
by: Sidi Driss El jaouhari, et al.
Published: (2017-04-01)

The use of 3 sugammadex out of 5 reversal of during recovery of rocuronium-induced neuromuscular blockade in a patient with post-tonsillectomy hemorrhage: a case report
by: Hee-Jong Lee, et al.
Published: (2014-07-01)

Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center
by: Carron M, et al.
Published: (2016-02-01)

REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study)
by: Massimiliano Greco, et al.
Published: (2023-01-01)

Use of rocuronium and sugammadex under neuromuscular transmission monitoring in a patient with multiple sclerosis
by: Chryssoula Staikou, et al.
Published: (2017-01-01)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
by: Soon Ho Cheong, et al.
Published: (2015-12-01)

Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study
by: Öznur ULUDAĞ
Published: (2019-05-01)

A Comparision of the Effect of Sugammadex on the Recovery Period and Postoperative Residual Block in Young Elderly and Middle-Aged Elderly Patients
by: Emine Yazar, et al.
Published: (2016-04-01)

Chronic exposure to dexamethasone may not affect sugammadex reversal of rocuronium-induced neuromuscular blockade: an in vivo study on rats
by: Ha Yeon Park, et al.
Published: (2023-07-01)

Efficacy and safety of sugammadex sodium in reversing rocuronium-induced neuromuscular blockade in children: An updated systematic review and meta-analysis
by: Sheng Zhou, et al.
Published: (2023-08-01)

Residual paralysis caused by 50 mg rocuronium after reversal with 4 mg/kg sugammadex: a case report
by: Kohji Uzawa, et al.
Published: (2021-05-01)

New way of dosing sugammadex for termination of vecuronium induced neuromuscular block
by: Blaž Peček, et al.
Published: (2015-06-01)

Influence of methylprednisolone on the reversal time of sugammadex: a randomized clinical trial
by: Merve Hayriye Kocaoğlu, et al.
Published: (2020-08-01)

Advantages and pitfalls of clinical application of sugammadex
by: Hyung Young Lee, et al.
Published: (2020-07-01)

Rocuronium and sugammadex: An alternative to succinylcholine for electro convulsive therapy in patients with suspected neuroleptic malignant syndrome
by: Karthik G Ramamoorthy, et al.
Published: (2011-01-01)

The relationship between the sugammadex use and postoperative reintubation in the absence of neuromuscular monitoring
by: Chung-Yi Wu, et al.
Published: (2022-01-01)

Sugammadex in Emergency Situations
by: Cyrus Motamed
Published: (2023-01-01)

Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study
by: M. Carron, et al.
Published: (2022-01-01)

Efficacy and safety of sugammadex in patients undergoing renal transplantation
by: Yasumasa Ono, et al.
Published: (2018-07-01)

Effects of hydrocortisone-presensitized sugammadex on recovery from neuromuscular blockade induced by rocuronium: a rodent in vivo study
by: Hey-Ran Choi, et al.
Published: (2022-04-01)

Myasthenia gravis and sugammadex: A case report and review of the literature
by: Sujana Dontukurthy, et al.
Published: (2020-01-01)

Use of sugammadex in patients with neuromuscular disorders: a systematic review of case reports
by: Usha Gurunathan, et al.
Published: (2019-11-01)